Lundbeck’s long experience and continuous work within diseases of the brain have provided us with a strong global network in preclinical and clinical neuroscience research. It is essential for us to maintain our strong internal R&D capabilities and to build external alliances to supplement our internal capabilities, taking advantage of the increased opportunities provided by innovative technologies.
In addition, Lundbeck joined the personal genetics company 23andMe, Inc. and the think tank The Milken Institute in a large new study to increase the understanding of the underlying causes of Major Depressive Disorder (MDD) and bipolar depression. This study further explores how these diseases and brain functions such as attention and decision-making are related to genetics.
Lundbeck also participates in the RADAR-CNS collaboration, designed to develop new ways of monitoring conditions such as MDD, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. Such widely available devices can remotely reveal a patient’s current condition at previously unachievable levels of detail.